RSV, or Respiratory Syncytial Virus, is a big deal for kids under two. It's a major reason why little ones end up in the hospital. A recent study looked at how RSV hospital stays affect families and healthcare systems in five European countries: Germany, Spain, Italy, France, and England. The study tracked kids under two who were hospitalized with RSV between 2020 a...
A recent study has brought good news for parents worried about RSV in their little ones. It turns out that babies can get an antibody shot to protect them from RSV, even if their moms were vaccinated during pregnancy. This shot, called nirsevimab, is a big deal because RSV is a common and serious respiratory infection for infants. The study looked at 181 pairs of mo...
In January 2024, Chinese officials gave the green light to nirsevimab. This drug is designed to shield infants from respiratory syncytial virus (RSV). In Shanghai, researchers wanted to see if using nirsevimab for babies was a good deal. They looked at two plans: giving the shot all year or just during certain months. They also considered two scenarios: if the shot w...
The 2023-2024 RSV season brought a new vaccine for adults aged 60 and above. This vaccine was recommended based on discussions between patients and their healthcare providers. A study was conducted to see how many people in Southern California got the vaccine and why some groups were more likely to get it than others. The study looked at over a million patients aged...
RSV, or Respiratory Syncytial Virus, is a big deal for seniors. It can cause serious breathing problems, leading to hospital visits and even death. Lately, three new vaccines have been approved for older adults. But will they take them? That's the question. To figure this out, we need to look at what influences their decisions. It's not just about knowing th...
Have you ever wondered how common and serious the respiratory syncytial virus (RSV) is among adults living in the UK? Surprisingly, we don't know much about this virus in adults because doctors don't usually test for it. This lack of information makes it hard to know if we need a vaccination program for adults. A new study is aiming to fill this gap by observing adul...
Between November last year and April this year, something unexpected happened in Jordan. Almost half of the kids under five who were hospitalized had a virus called respiratory syncytial virus, or RSV for short. This virus isn't as famous as others, but it can lead to serious breathing issues like bronchiolitis and pneumonia. These problems often need special care, s...
As the holidays come to an end, so do the festivities for many families in Chicago. Instead of celebrating, they're dealing with a wave of illnesses. Flu and RSV, a respiratory virus, are on the rise, making their way through the city like a storm. Doctors say it's not surprising, as this time of year is always tough on our immune systems. Take Leslee Cohen-Lavin's ...
Respiratory syncytial virus, often called RSV, is a big problem for little kids. Babies under a year old get sick the most from this virus. Recently, Australia approved a new vaccine that protects moms during pregnancy, so their babies stay healthier. It's a smart move to check if this vaccine is worth it for Australia's money and health. First, let's talk about the...
Wisconsin health officials are calling for people to get their flu and COVID-19 vaccines before the holidays. They say only 22% of people have gotten a flu shot and 11% have received an updated COVID-19 shot. This is worrying because respiratory viruses like RSV usually spike this time of year. Dr. Stephanie Schauer from the Wisconsin Department of Health Services ad...